Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Last updated: May 19, 2025
Sponsor: Momentum Data
Overall Status: Completed

Phase

N/A

Condition

Dermatitis, Atopic

Eczema (Atopic Dermatitis)

Atopic Dermatitis

Treatment

No intervention

Clinical Study ID

NCT03823794
P002
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.

Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All paediatric and adult patients registered with an Royal College of GeneralPractitioners (RCGP) Research and Surveillance Centre (RSC) contributing GP practiceduring the study period (2008-2018) and with at least one year of follow-up.

Exclusion

Exclusion Criteria:

  • The presence of psoriasis, photodermatitis, or ichthyosis

Study Design

Total Participants: 148166
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
February 01, 2019
Estimated Completion Date:
November 04, 2020

Study Description

Objective

The study aims to describe the health care resource utilisation of patients with active AD in terms of prescription use, primary care appointments, and specialist referrals.

Method This study will define AD cases using a previously validated algorithm for case identification use clinical codes form primary care in the UK (Read codes). The study will analyse a cohort of prevalent active AD cases over a one year period (2018). The annual use of topical and oral medications used for the treatment of AD, primary care appointments, and specialist referrals will be reported.

Connect with a study center

  • Momentum Data Ltd

    London, WC1X 8QT
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.